ATP-Citrate Lyase Epigenetically Potentiates Oxidative Phosphorylation to Promote Melanoma Growth and Adaptive Resistance to MAPK Inhibition

Weinan Guo, Jinyuan Ma, Yuqi Yang, Sen Guo, Weigang Zhang, Tao Zhao, Xiuli Yi, Huina Wang, Shiyu Wang, Yu Liu, Wei Dai, Xuguang Chen, Qiong Shi, Gang Wang, Tianwen Gao, Chunying LiClinical 2020 · DOI

Abstract

We demonstrate that ACLY epigenetically potentiates oxidative phosphorylation to promote melanoma growth and MAPK inhibition adaptive resistance. Our study discovers the novel crosstalk between lipogenesis and mitochondrial function in tumor biology and highlights targeting ACLY as a potent therapeutic approach via simultaneously impairing tumor growth and MAPK inhibition resistance in melanoma.
BibTeX
@inproceedings{guo2020atp,
  author = {Weinan Guo and Jinyuan Ma and Yuqi Yang and Sen Guo and Weigang Zhang and Tao Zhao and Xiuli Yi and Huina Wang and Shiyu Wang and Yu Liu and Wei Dai and Xuguang Chen and Qiong Shi and Gang Wang and Tianwen Gao and Chunying Li},
  title = {{ATP-Citrate Lyase Epigenetically Potentiates Oxidative Phosphorylation to Promote Melanoma Growth and Adaptive Resistance to MAPK Inhibition}},
  booktitle = {Clinical},
  year = {2020},
  doi = {10.1158/1078-0432.ccr-19-1359},
}

Loading related content...

Figure